Early age at time of primary epstein-barr virus infection results in poorly controlled viral infection in infants from western Kenya: Clues to the etiology of endemic Burkitt lymphoma

Journal of Infectious Diseases

Volumn 205, Issue 6, 2012, Pages 906-913

  Piriou, Erwan ^a,b   Asito, Amolo S ^b,c   Sumba, Peter O ^b   Fiore, Nancy ^a   Middeldorp, Jaap M ^d   Moormann, Ann M ^e   Ploutz Snyder, Robert ^a,f   Rochford, Rosemary ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MASENO UNIVERSITY   (Kenya)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

AGE DISTRIBUTION; ARTICLE; BURKITT LYMPHOMA; CANCER RISK; CHILD; CONTROLLED STUDY; DISEASE DURATION; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; INFECTION CONTROL; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; ONSET AGE; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; RESIDENTIAL AREA; RISK ASSESSMENT; RURAL AREA; VIRUS CARCINOGENESIS; VIRUS LOAD;

ANTIBODIES, VIRAL; BURKITT LYMPHOMA; CHILD, PRESCHOOL; DNA, PROTOZOAN; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GEOGRAPHY; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; KENYA; LONGITUDINAL STUDIES; MALARIA; MALE; PARASITEMIA; VIRAL LOAD;

EID: 84857550061     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir872     Document Type: Article

References (33)

1. Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Int Health 2007;12:936-43.
2. Facer CA, Playfair JH. Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res 1989;53:33-72.
3. Morrow RH. Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. In: Lenoir G, O'Connor G, Olweny C, eds. Burkitt's lymphoma: a human cancer model. Lyon, France: IARC Press, 1985:177-85.
4. De-Thé G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978;274:756-61.
5. De-Thé G. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited. IARC Sci Publ 1985;60:165-76.
6. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1978;22:239-43.
7. Biggar RJ, Henle G, Bocker J, Lennette ET, Fleisher G, Henle W. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer 1978;22:244-50.
8. Chan KH, Tam JS, Peiris JS, Seto WH, Ng MH. Epstein-Barr virus (EBV) infection in infancy. J Clin Virol 2001;21:57-62.
9. Jenson H, McIntosh K, Pitt J, et al. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis 1999;179:1395-404.
10. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997;349:1650-4.
11. Mbogo CN, Snow RW, Khamala CP, et al. Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. Am J Trop Med Hyg 1995;52:201-6.
12. Rainey JJ, Omenah D, Sumba PO, Moormann AM, Rochford R, Wilson ML. Spatial clustering of endemic Burkitt's lymphoma in highrisk regions of Kenya. Int J Cancer 2007;120:121-7.
13. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005;191:1233-8.
14. De-Thé G. Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1977;1:335-8.
15. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 2007;195:799-808.
16. Hermsen CC, Telgt DS, Linders EH, et al. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol 2001;118:247-51.
17. Fachiroh J, Paramita DK, Hariwiyanto B, et al. Single-assay combination of Epstein-Barr virus (EBV) EBNA1-and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. J Clin Microbiol 2006;44:1459-67.
18. Middeldorp JM, Meloen RH. Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J Virol Methods 1988;21:147-59.
19. van Grunsven WM, Spaan WJ, Middeldorp JM. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis 1994;170:13-9.
20. Stata statistical software. Release 11 ed. College Station, TX: Stata-Corp, LP, 2009.
21. Menge DM, Ernst KC, Vulule JM, Zimmerman PA, Guo H, John CC. Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area. Am J Trop Med Hyg 2008;79:173-7.
22. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Vol. 2. Philadelphia, PA: Lippincott & Williams, 2006:2655-700.
23. Huang LM, Lee CY, Chang MH, Wang JD, Hsu CY. Primary infections of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6. Arch Dis Child 1993;68:408-11.
24. Ptaschinski C, Rochford R. Infection of neonates with murine gammaherpesvirus 68 results in enhanced viral persistence in lungs and absence of infectious mononucleosis syndrome. J Gen Virol 2008;89:1114-21.
25. Cote PJ, Korba BE, Miller RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000;31:190-200.
26. Tu W, Chen S, Sharp M, et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004;172:3260-7.
27. Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 2005;61:461-5.
28. Piriou E, Kimmel R, Chelimo K, et al. Serological evidence for longterm Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol 2009;81:1088-93.
29. Chene A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 2007;3:e80.
30. Asito AS, Piriou E, Odada PS, et al. Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study. Infect Agent Cancer 2010;5:13.
31. Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001;39:1211-6.
32. Kelly GL, Rickinson AB. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematol Am Soc Hematol Educ Program 2007;277-84.
33. Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 2004;78:5194-204.